Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
03/13/2024
Jolynn Tumolo
Stason Pharmaceuticals Inc. is recalling 54,131 bottles of mercaptopurine tablets manufactured for Quinn Pharmaceuticals, Boca Raton, Florida.
Stason Pharmaceuticals Inc. is recalling 54,131 bottles of mercaptopurine tablets manufactured for Quinn Pharmaceuticals, Boca Raton, Florida.
Stason Pharmaceuticals Inc. is...
03/13/2024
Pharmacy Learning Network
News
03/12/2024
Jolynn Tumolo
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force...
03/12/2024
First Report Managed Care
News
03/12/2024
Jolynn Tumolo
The US Department of Veterans Affairs (VA) is partnering with Department of Defense (DOD) to increase veteran access to VA health care in Tennessee and Kentucky.
The US Department of Veterans Affairs (VA) is partnering with Department of Defense (DOD) to increase veteran access to VA health care in Tennessee and Kentucky.
The US Department of Veterans...
03/12/2024
Veterans Health Today
News
03/07/2024
Jolynn Tumolo
Bausch Health Companies Inc. is recalling 3600 cartons of omeprazole and sodium bicarbonate powder for oral suspension distributed by Oceanside Pharmaceuticals.
Bausch Health Companies Inc. is recalling 3600 cartons of omeprazole and sodium bicarbonate powder for oral suspension distributed by Oceanside Pharmaceuticals.
Bausch Health Companies Inc. is...
03/07/2024
Pharmacy Learning Network
News
03/07/2024
Jolynn Tumolo
Sun Pharmaceuticals is recalling mesalamine extended-release capsules after samples failed to meet dissolution specifications during routine testing.
Sun Pharmaceuticals is recalling mesalamine extended-release capsules after samples failed to meet dissolution specifications during routine testing.
Sun Pharmaceuticals is recalling...
03/07/2024
Pharmacy Learning Network
News
03/06/2024
Jolynn Tumolo
The ointments were distributed by Walmart, CVS, and AACE Pharmaceuticals.
The ointments were distributed by Walmart, CVS, and AACE Pharmaceuticals.
The ointments were distributed...
03/06/2024
Pharmacy Learning Network
News
03/05/2024
Jolynn Tumolo
Moderna’s experimental respiratory syncytial virus (RSV) vaccine is garnering high expectations from investors, according to a recent Biopharma Dive article.
Moderna’s experimental respiratory syncytial virus (RSV) vaccine is garnering high expectations from investors, according to a recent Biopharma Dive article.
Moderna’s experimental...
03/05/2024
Pharmacy Learning Network
News
03/04/2024
Jolynn Tumolo
Effective March 5, 2024, the US Department of Veterans Affairs (VA) is expanding VA health care eligibility to include all veterans who were exposed to toxins and other hazards while serving in the military at home or abroad.
Effective March 5, 2024, the US Department of Veterans Affairs (VA) is expanding VA health care eligibility to include all veterans who were exposed to toxins and other hazards while serving in the military at home or abroad.
Effective March 5, 2024, the US...
03/04/2024
Veterans Health Today
Doctors examine brain scans
News
03/04/2024
Jolynn Tumolo
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients...
03/04/2024
Neurology
News
03/01/2024
Jolynn Tumolo
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the...
03/01/2024
Pharmacy Learning Network